Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
5.85
-0.05 (-0.85%)
At close: Nov 5, 2026, 4:00 PM EST
5.76
-0.09 (-1.54%)
After-hours: Nov 5, 2026, 7:30 PM EST
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Emergent BioSolutions the 15,646th largest employer in the world and 2,253rd in the United States.
Employees
900
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$721,222
Profits / Employee
-$289,667
Market Cap
300.78M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 900 | 0 | - |
| Dec 31, 2024 | 900 | -700 | -43.75% |
| Dec 31, 2023 | 1,600 | -900 | -36.00% |
| Dec 31, 2022 | 2,500 | 84 | 3.48% |
| Dec 31, 2021 | 2,416 | 216 | 9.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 3,595 |
| Canopy Growth | 1,128 |
| Aurora Cannabis | 1,028 |
| Kamada | 462 |
| Glass House Brands | 426 |
| Lifecore Biomedical | 382 |
| Evolus | 353 |
| Anika Therapeutics | 235 |
EBS News
- 1 day ago - Emergent BioSolutions Receives $22.3 Million Delivery Order Modification to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War - Business Wire
- 2 days ago - Emergent BioSolutions trading resumes - TheFly
- 2 days ago - Emergent BioSolutions trading halted, volatility trading pause - TheFly
- 3 days ago - Emergent BioSolutions Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Emergent BioSolutions Earnings release: Q3 2026 - Filings
- 3 days ago - Emergent BioSolutions Slides: Q3 2026 - Filings
- 3 days ago - Emergent BioSolutions Quarterly report: Q3 2026 - Filings
- 3 days ago - Emergent BioSolutions reports Q3 adjusted EPS (36c), two estimates (39c) - TheFly